Hybrid cardiac imaging using PET/MRI: a joint position statement by the European Society of Cardiovascular Radiology (ESCR) and the European Association of Nuclear Medicine (EANM)

TY - JOUR

T1 - Hybrid cardiac imaging using PET/MRI

T2 - a joint position statement by the European Society of Cardiovascular Radiology (ESCR) and the European Association of Nuclear Medicine (EANM)

AU - Nensa, Felix

AU - Bamberg, Fabian

AU - Rischpler, Christoph

AU - Menezes, Leon

AU - Poeppel, Thorsten D

AU - la Fougère, Christian

AU - Beitzke, Dietrich

AU - Rasul, Sazan

AU - Loewe, Christian

AU - Nikolaou, Konstantin

AU - Bucerius, Jan

AU - Kjaer, Andreas

AU - Gutberlet, Matthias

AU - Prakken, Niek H

AU - Vliegenthart, Rozemarijn

AU - Slart, Riemer H J A

AU - Nekolla, Stephan G

AU - Lassen, Martin L

AU - Pichler, Bernd J

AU - Schlosser, Thomas

AU - Jacquier, Alexis

AU - Quick, Harald H

AU - Schäfers, Michael

AU - Hacker, Marcus

AU - European Society of Cardiovascular Radiology (ESCR)

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Abstract: Positron emission tomography (PET) and magnetic resonance imaging (MRI) have both been used for decades in cardiovascular imaging. Since 2010, hybrid PET/MRI using sequential and integrated scanner platforms has been available, with hybrid cardiac PET/MR imaging protocols increasingly incorporated into clinical workflows. Given the range of complementary information provided by each method, the use of hybrid PET/MRI may be justified and beneficial in particular clinical settings for the evaluation of different disease entities. In the present joint position statement, we critically review the role and value of integrated PET/MRI in cardiovascular imaging, provide a technical overview of cardiac PET/MRI and practical advice related to the cardiac PET/MRI workflow, identify cardiovascular applications that can potentially benefit from hybrid PET/MRI, and describe the needs for future development and research. In order to encourage its wide dissemination, this article is freely accessible on the European Radiology and European Journal of Hybrid Imaging web sites. Key Points: • Studies and case-reports indicate that PET/MRI is a feasible and robust technology. • Promising fields of application include a variety of cardiac conditions. • Larger studies are required to demonstrate its incremental and cost-effective value. • The translation of novel radiopharmaceuticals and MR-sequences will provide exciting new opportunities.

AB - Abstract: Positron emission tomography (PET) and magnetic resonance imaging (MRI) have both been used for decades in cardiovascular imaging. Since 2010, hybrid PET/MRI using sequential and integrated scanner platforms has been available, with hybrid cardiac PET/MR imaging protocols increasingly incorporated into clinical workflows. Given the range of complementary information provided by each method, the use of hybrid PET/MRI may be justified and beneficial in particular clinical settings for the evaluation of different disease entities. In the present joint position statement, we critically review the role and value of integrated PET/MRI in cardiovascular imaging, provide a technical overview of cardiac PET/MRI and practical advice related to the cardiac PET/MRI workflow, identify cardiovascular applications that can potentially benefit from hybrid PET/MRI, and describe the needs for future development and research. In order to encourage its wide dissemination, this article is freely accessible on the European Radiology and European Journal of Hybrid Imaging web sites. Key Points: • Studies and case-reports indicate that PET/MRI is a feasible and robust technology. • Promising fields of application include a variety of cardiac conditions. • Larger studies are required to demonstrate its incremental and cost-effective value. • The translation of novel radiopharmaceuticals and MR-sequences will provide exciting new opportunities.

KW - Cardiac Imaging Techniques

KW - Heart Diseases/diagnostic imaging

KW - Humans

KW - Magnetic Resonance Imaging/methods

KW - Multimodal Imaging/methods

KW - Nuclear Medicine/methods

KW - Positron-Emission Tomography/methods

KW - Radiopharmaceuticals

KW - Tomography, X-Ray Computed/methods

U2 - 10.1007/s00330-017-5008-4

DO - 10.1007/s00330-017-5008-4

M3 - Review

C2 - 29717368

SN - 0938-7994

VL - 28

SP - 4086

EP - 4101

JO - European Radiology

JF - European Radiology

IS - 10

ER -